Go to main menuGo to search engineSkip to content

Digital Medical Library

Back to results

Economic Evaluation of Crohn’s Disease Treatment with Vedolizumab and Ustekinumab After Failure of Tumour Necrosis Factor-alpha Antagonist

Preview format:

We use files, through the cookie quality improvement layer of our website.For more information, please read the document
Privacy Policy